Omega Healthcare Investors (NYSE:OHI) Announces Earnings Results

Omega Healthcare Investors (NYSE:OHI) posted its earnings results on Wednesday. The real estate investment trust reported $1.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.51 by $0.68, FiscalAI reports. The business had revenue of $328.25 million for the quarter, compared to analysts’ expectations of $266.97 million. Omega Healthcare Investors had a net margin of 51.14% and a return on equity of 11.86%. The business’s revenue for the quarter was up 16.2% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.77 EPS. Omega Healthcare Investors updated its FY 2026 guidance to 3.220-3.260 EPS.

Omega Healthcare Investors Stock Performance

Shares of OHI stock traded down $1.12 during mid-day trading on Thursday, reaching $50.24. 855,205 shares of the company’s stock traded hands, compared to its average volume of 2,126,377. The company has a debt-to-equity ratio of 0.81, a quick ratio of 5.32 and a current ratio of 5.32. The firm has a market capitalization of $14.96 billion, a PE ratio of 24.27, a price-to-earnings-growth ratio of 2.20 and a beta of 0.58. Omega Healthcare Investors has a 12 month low of $38.71 and a 12 month high of $52.39. The firm has a 50 day moving average price of $47.65 and a two-hundred day moving average price of $46.59.

Omega Healthcare Investors Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Stockholders of record on Monday, August 3rd will be given a dividend of $0.68 per share. This represents a $2.72 dividend on an annualized basis and a dividend yield of 5.4%. The ex-dividend date of this dividend is Monday, August 3rd. This is a positive change from Omega Healthcare Investors’s previous quarterly dividend of $0.67. Omega Healthcare Investors’s payout ratio is presently 129.47%.

Key Omega Healthcare Investors News

Here are the key news stories impacting Omega Healthcare Investors this week:

• Positive Sentiment: Second-quarter funds from operations (FFO) came in at $0.83 per share, above the $0.80 consensus estimate and up from $0.77 a year earlier. Revenue of $328.25 million exceeded expectations of $266.97 million and increased 16.2% year over year. Omega Healthcare Investors Q2 FFO and Revenues Beat Estimates
• Positive Sentiment: The company reported quarterly EPS of $1.19, significantly above the $0.51 analyst estimate, while net margin was 51.14%. The earnings strength was attributed in part to accretive investment activity, which can support future earnings and cash flow. Omega Healthcare Investors Q2 earnings top consensus on accretive investment activity
• Positive Sentiment: Omega raised or reaffirmed fiscal 2026 EPS guidance at $3.22-$3.26, above the approximately $3.10 consensus forecast. This suggests management remains confident in operating performance and investment returns. Omega Reports Second Quarter 2026 Results and Recent Developments
• Neutral Sentiment: The supplied reports do not identify a new company-specific negative development. OHI’s recent pullback may instead reflect profit-taking or valuation concerns after the stock approached its 52-week high, despite the favorable earnings update.

Institutional Trading of Omega Healthcare Investors

Hedge funds have recently bought and sold shares of the stock. State Street Corp raised its stake in shares of Omega Healthcare Investors by 4.8% in the second quarter. State Street Corp now owns 14,591,873 shares of the real estate investment trust’s stock worth $534,792,000 after buying an additional 671,473 shares during the period. Invesco Ltd. increased its holdings in Omega Healthcare Investors by 8.6% in the 4th quarter. Invesco Ltd. now owns 5,368,945 shares of the real estate investment trust’s stock worth $238,059,000 after acquiring an additional 424,024 shares in the last quarter. Charles Schwab Investment Management Inc. raised its stake in Omega Healthcare Investors by 4.1% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 4,463,838 shares of the real estate investment trust’s stock worth $197,927,000 after acquiring an additional 174,062 shares during the period. Dimensional Fund Advisors LP raised its stake in Omega Healthcare Investors by 2.5% during the 4th quarter. Dimensional Fund Advisors LP now owns 4,314,384 shares of the real estate investment trust’s stock worth $191,305,000 after acquiring an additional 103,201 shares during the period. Finally, Deutsche Bank AG lifted its holdings in Omega Healthcare Investors by 12.2% during the fourth quarter. Deutsche Bank AG now owns 3,615,837 shares of the real estate investment trust’s stock valued at $160,326,000 after purchasing an additional 392,575 shares in the last quarter. Institutional investors own 65.25% of the company’s stock.

Analysts Set New Price Targets

OHI has been the topic of a number of research analyst reports. Truist Financial lowered their price objective on shares of Omega Healthcare Investors from $48.00 to $46.00 and set a “hold” rating on the stock in a research report on Tuesday, June 9th. Citigroup reaffirmed a “market perform” rating on shares of Omega Healthcare Investors in a research report on Monday, June 15th. Barclays began coverage on Omega Healthcare Investors in a report on Tuesday, July 7th. They set an “underweight” rating and a $51.00 price target on the stock. Royal Bank Of Canada raised their price target on Omega Healthcare Investors from $47.00 to $48.00 and gave the stock a “sector perform” rating in a research note on Monday, May 4th. Finally, Weiss Ratings raised Omega Healthcare Investors from a “buy (b)” rating to a “buy (b+)” rating in a report on Tuesday, June 30th. Five equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and two have issued a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $48.50.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company’s core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.